Advertisement
Advertisement

MRK

MRK logo

Merck & Co., Inc.

119.05
USD
Sponsored
-1.71
-1.42%
Jun 12, 16:00 UTC -4
Closed
exchange

After-Market

119.24

+0.19
+0.16%

MRK Earnings Reports

Positive Surprise Ratio

MRK beat 35 of 41 last estimates.

85%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$16.52B
/
$2.12
Implied change from Q1 26 (Revenue/ EPS)
+1.46%
/
-265.63%
Implied change from Q2 25 (Revenue/ EPS)
+4.54%
/
-3.20%

Merck & Co., Inc. earnings per share and revenue

On Apr 30, 2026, MRK reported earnings of -1.28 USD per share (EPS) for Q1 26, beating the estimate of -1.52 USD, resulting in a 16.00% surprise. Revenue reached 16.29 billion, compared to an expected 15.98 billion, with a 1.91% difference. The market reacted with a -1.60% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 12 analysts forecast an EPS of 2.12 USD, with revenue projected to reach 16.52 billion USD, implying an decrease of -265.63% EPS, and increase of 1.46% in Revenue from the last quarter.
FAQ
For Q1 2026, Merck & Co., Inc. reported EPS of -$1.28, beating estimates by 16%, and revenue of $16.29B, 1.91% above expectations.
The stock price moved down -1.6%, changed from $110.95 before the earnings release to $109.18 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 12 analysts, Merck & Co., Inc. is expected to report EPS of $2.12 and revenue of $16.52B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement